Martingale Asset Management L P Edgewise Therapeutics, Inc. Transaction History

Martingale Asset Management L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$5.51 - $12.1 $55 - $121	-10 Reduced 0.02%	61,384 $671,000
Q3 2023 Nov 14, 2023	SELL	$5.73 - $7.69 $57 - $76	-10 Reduced 0.02%	61,394 $351,000
Q2 2023 Aug 11, 2023	BUY	$5.71 - $10.29 $26,500 - $47,755	4,641 Added 8.18%	61,404 $475,000
Q1 2023 May 12, 2023	BUY	$6.66 - $11.33 $185,814 - $316,107	27,900 Added 96.66%	56,763 $378,000
Q4 2022 Feb 13, 2023	BUY	$7.58 - $11.08 $27,651 - $40,419	3,648 Added 14.47%	28,863 $258,000
Q3 2022 Nov 14, 2022	BUY	$8.08 - $13.58 $203,737 - $342,419	25,215 New	25,215 $249,000

191

100M

2.17M

410K

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.94B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.